GO enrichment analysis demonstrated that compounds in CF may affect a variety of biological processes, including inflammatory response, response to lipopolysaccharides, protein phosphorylation, positive regulation of the ERK1 and ERK2 cascade, and negative regulation of the apoptotic process, all of which may be associated with its anti-AD effects (Fig. 8). The gene discussed is MAPK1; the disease is cystic fibrosis.